Keyphrases
AIDS Patients
100%
HHV-8
100%
Oral Plasmablastic Lymphoma
100%
Lymphoma
75%
Oral Cavity
62%
Epstein-Barr Virus
37%
Tumor Cells
25%
Plasmablastic Lymphoma
25%
Immunosuppression
12%
T Cells
12%
Virus
12%
Malignancy
12%
Tumor
12%
Kaposi Sarcoma
12%
Human Immunodeficiency Virus Type 1 (HIV-1)
12%
Poor Prognosis
12%
In Situ Hybridization
12%
Immunohistochemistry
12%
In Situ
12%
HIV RNA
12%
Diffuse Large B-cell Lymphoma (DLBCL)
12%
Immunocompromised Patients
12%
Epstein-Barr Virus Infections
12%
Polymerase Chain Reaction
12%
Reverse Transcriptase
12%
Neoplastic Cells
12%
Therapeutic Value
12%
Primary Effusion Lymphoma
12%
Castleman Disease
12%
EBER1
12%
Medicine and Dentistry
Human Herpesvirus 8
100%
Plasmablastic Lymphoma
100%
Herpes Simplex Virus
87%
Oral Cavity
62%
Epstein Barr Virus
37%
Infection
25%
Human Immunodeficiency Virus
25%
Tumor Cell
25%
T Cell
12%
Neoplasm
12%
Cancer
12%
Kaposi Sarcoma
12%
Immunosuppressive Treatment
12%
Diffuse Large B-Cell Lymphoma
12%
Epstein-Barr Virus Infection
12%
Immunohistochemistry
12%
Polymerase Chain Reaction
12%
Immunocompromised Patient
12%
in Situ Hybridization
12%
RNA Directed DNA Polymerase
12%
Angiofollicular Lymph Node Hyperplasia
12%
Primary Effusion Lymphoma
12%